Blog

A targeted rheumatic heart disease and matched healthy-control serum collection completed in approximately two months.

August 13, 2026

High-quality HIV biospecimens are essential for developing and validating accurate diagnostic assays. A recent peer-reviewed study published in the Journal of Clinical Virology Plus demonstrated excellent analytical and clinical agreement for the Siemens Healthineers HIV Antigen/Antibody Combo assay across multiple automated testing platforms. The study utilized well-characterized HIV-positive and HIV-negative serum specimens, including samples sourced […]

July 14, 2026

Learn how Boca Bio successfully completed a prospective collection of 500 plasma specimens from healthy adults aged 60+ across six U.S. clinical sites. Discover how standardized plasma processing, multi-site clinical operations, and sponsor-specific protocols supported high-quality biospecimens for biomarker research.

July 11, 2026

Clinical trial success depends on more than patient recruitment. Learn why high-quality clinical data, biospecimen integrity, and operational excellence are becoming critical competitive advantages in modern clinical research.

June 18, 2026

Selecting the right biospecimen and lab testing services partner is critical for generating reliable data, accelerating timelines, and supporting regulatory success. This blog outlines seven key factors pharma and IVD teams should evaluate, including biospecimen access, CLIA-certified testing, biomarker expertise, regulatory experience, data traceability, and integrated laboratory services. Learn how the right partner can help […]

May 19, 2026